InsiderTrades

Form 4 for XLO Xilio Therapeutics, Inc.

Accepted 2021-10-28 00:00:00 ET · period of report 2021-10-26 · accession 0000315066-21-001812 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DMI 2021-10-28 2021-10-26 XLO FMR LLC See Remark 1 C - Cnv Deriv — +1.88M 815.8K New —
DMI 2021-10-28 2021-10-26 XLO FMR LLC See Remark 1 C - Cnv Deriv — -17.87M 0 -100% —

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2021-10-26 C A 4,465 — 4,465 I F-Prime Capital Partners Healthcare Advisors Fund IV LP — — (F1) On October 26, 2021, in connection with the completion of the issuer's initial public offering, each share of Series A, A-1, and B Preferred Stock converted on a 1-for-9.5 basis into shares of Common Stock.
2 Common Common Stock 2021-10-26 C A 686,499 — 1,502,287 I F-Prime Capital Partners Healthcare Fund IV LP — — (F1) On October 26, 2021, in connection with the completion of the issuer's initial public offering, each share of Series A, A-1, and B Preferred Stock converted on a 1-for-9.5 basis into shares of Common Stock.
3 Common Common Stock 2021-10-26 C A 28,703 — 1,530,990 I F-Prime Capital Partners Healthcare Fund IV LP — — (F1) On October 26, 2021, in connection with the completion of the issuer's initial public offering, each share of Series A, A-1, and B Preferred Stock converted on a 1-for-9.5 basis into shares of Common Stock.
4 Common Common Stock 2021-10-26 C A 372,215 — 372,215 I Impresa Fund III Limited Partnership — — (F1) On October 26, 2021, in connection with the completion of the issuer's initial public offering, each share of Series A, A-1, and B Preferred Stock converted on a 1-for-9.5 basis into shares of Common Stock.
5 Common Common Stock 2021-10-26 C A 789,473 — 815,788 I F-Prime Capital Partners Healthcare Fund IV LP — — (F1) On October 26, 2021, in connection with the completion of the issuer's initial public offering, each share of Series A, A-1, and B Preferred Stock converted on a 1-for-9.5 basis into shares of Common Stock.
6 Derivative Series B Preferred Stock 2021-10-26 C D 42,421 — 0 I F-Prime Capital Partners Healthcare Advisors Fund IV LP — · — to — 4,465 Common Stock (F1) On October 26, 2021, in connection with the completion of the issuer's initial public offering, each share of Series A, A-1, and B Preferred Stock converted on a 1-for-9.5 basis into shares of Common Stock.
7 Derivative Series B Preferred Stock 2021-10-26 C D 3,536,046 — 0 I Impresa Fund III Limited Partnership — · — to — 372,215 Common Stock (F1) On October 26, 2021, in connection with the completion of the issuer's initial public offering, each share of Series A, A-1, and B Preferred Stock converted on a 1-for-9.5 basis into shares of Common Stock.
8 Derivative Series B Preferred Stock 2021-10-26 C D 272,687 — 0 I F-Prime Capital Partners Healthcare Fund IV LP — · — to — 28,703 Common Stock (F1) On October 26, 2021, in connection with the completion of the issuer's initial public offering, each share of Series A, A-1, and B Preferred Stock converted on a 1-for-9.5 basis into shares of Common Stock.
9 Derivative Series A-1 Preferred Stock 2021-10-26 C D 6,521,739 — 0 I F-Prime Capital Partners Healthcare Fund IV LP — · — to — 686,499 Common Stock (F1) On October 26, 2021, in connection with the completion of the issuer's initial public offering, each share of Series A, A-1, and B Preferred Stock converted on a 1-for-9.5 basis into shares of Common Stock.
10 Derivative Series A Preferred Stock 2021-10-26 C D 7,500,000 — 0 I F-Prime Capital Partners Healthcare Fund IV LP — · — to — 789,473 Common Stock (F1) On October 26, 2021, in connection with the completion of the issuer's initial public offering, each share of Series A, A-1, and B Preferred Stock converted on a 1-for-9.5 basis into shares of Common Stock.